Neptinib
Neptinib (NEP010) is an orally active derivative of Afatinib (HY-10261) that has stronger antitumor activity than Afatinib (HY-10261) by improving pharmacokinetics. Neptinib has a significant inhibitory effect on tumor growth in mouse non-small cell lung cancer models with different EGFR mutations. Neptinib has a certain inhibitory effect on the EGFR kinase family, with IC50 values ??of 0.24 nM, 7.25 nM, 0.46 nM and 1.79 nM for EGFRwt, EGFRL858R/T790M, EGFRL858R and EGFRT790M, respectively.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2085843-51-0
- Formule: C22H23ClFN5O2
- Masse moléculaire:443.90
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform EGFR
More
Activité biologique
|
EGFR (WT) 0.24 nM (IC50) |
EGFRL858R/T790M 7.25 nM (IC50) |
EGFRL858R 0.46 nM (IC50) |
EGFRT790M 1.79 nM (IC50) |
Chemical Information
-
CAS No. 2085843-51-0
-
Masse moléculaire 443.90
-
Formule C22H23ClFN5O2
-
SMILES
FC(C=C1)=C(Cl)C=C1NC2=NC=NC3=C2C=C(NC(/C=C/CN(C)C)=O)C(OCC)=C3
-
Synonyms
NEP010
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)